The global antiseptic and disinfectant market size was valued at USD 29.15 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 10.49% from 2023 to 2030. Increase in prevalence of diseases such as typhoid, cholera, hepatitis A, food poisoning, and dengue, primarily due to lack of home cleanliness, is one of the major factors expected to drive antiseptics & disinfectants market growth. For instance, as per a report published by WHO in 2022, Over the last two decades, the number of dengue cases reported to WHO has surged by more than 8 fold, from 505,430 cases in 2000 to over 2.4 million in 2010, and 5.2 million in 2019. Such diseases are mainly caused by viruses, bacteria, & germs, which thrive in unhealthy home environments and unhygienic toilets, latrines, & kitchens.
The application of antiseptic and disinfectant solutions is, therefore, an essential requirement to maintain home cleanliness. Such solutions prevent growth of harmful bacteria and viruses, reducing the chance of acquiring these diseases. Hence, increase in awareness about home cleanliness is anticipated to propel the market over the forecast period.
The ongoing COVID-19 outbreak is expected to have a substantial impact on the antiseptics and disinfectants market. The COVID-19 pandemic, as well as an overall increase in hospital admissions around the world, has boosted demand for medical disposables. To meet rising worldwide demand such as long used for cleaning, deodorizing and disinfecting power in high-traffic facilities, including hospitals, nursing homes, office buildings, hotels, schools, due to COVID-19 outbreak, the WHO has urged industry and governments to expand production of antiseptics and disinfectants.
Increasing incidence of Healthcare-Associated Infections (HAIs) due to lack of precaution and sanitation is one of the leading factors contributing to market growth. For instance, as per the Healthcare-Associated Infections in 2020, every year, around one in every 25 hospital patients acquires at least one HAI. Antiseptics and disinfectants offer general anti-contamination protection and can help reduce the incidence of HAIs. They can also keep bacterial and other microbial diseases from entering the body of a patient. Over the forecast period, these factors are expected to drive market expansion.
Growing number of surgeries globally is also a key factor expected to drive the market growth over the forecast period. For instance, as per the Mölnlycke Health Care AB, 70 million surgical procedures are performed every year in Europe. Similarly, according to the Healthcare Cost and Utilization Project (HCUP), in 2018, more than 9,942,000 surgeries were performed in the U.S. within ambulatory care settings. In case of surgeries, the use of antiseptics & disinfectant products is one of the essential requirement in hospitals, clinics, and ambulatory surgery centers. Therefore, such instances are expected to drive the antiseptics & disinfectants market growth.
Disinfecting compounds are widely used as surface disinfectants in hospitals and laboratories. These compounds aid in controlling the spread of healthcare-associated infections in hospitals and clinics. In addition, it is also used for disinfecting medical equipment that come into direct contact with skin. Rising incidence of hospital-acquired infections across the globe is likely to positively impact the segment growth. For instance, as per WHO, every year, 7 out of every 100 hospitalized patients in industrialized nations and 10 out of every 100 hospitalized patients in underdeveloped countries acquire at least one healthcare-associated infection.
Reference:
